Literature DB >> 3775237

Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis.

H Gilljam, B Strandvik, A Ellin, L G Wiman.   

Abstract

The fatty acid pattern of the phospholipids in the bronchial secretion of patients with cystic fibrosis (CF) showed an increase of the mole fraction of arachidonic acid (AA) in most phospholipid classes compared to normals. Increase of AA in some classes was also found in patients with chronic bronchitis and in patients chronically colonized with Pseudomonas aeruginosa but in the diphosphatidylglycerol, lysophosphatidylethanolamine and sphingomyelin phospholipids, high fractions of AA was found exclusively in CF patients. Arachidonic acid was found to attain the highest ratios in CF in seven of the nine major bronchial phospholipids compared to the controls. There was no difference in the ratio saturated/unsaturated fatty acids between the CF patients and the control groups. A tendency towards unsaturation of the fatty acids in the bronchial secretion seems to be characteristic of infection and inflammation but AA appears to be more markedly increased in CF. Thus, the recorded changes may be characteristic for CF and not secondary to infection and/or inflammation in general, nor to P. aeruginosa colonization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3775237     DOI: 10.3109/00365518609083706

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  14 in total

1.  Linoleic acid supplement in cystic fibrosis: friend or foe?

Authors:  Neeraj Vij
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-13       Impact factor: 5.464

2.  A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.

Authors:  S D Freedman; M H Katz; E M Parker; M Laposata; M Y Urman; J G Alvarez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.

Authors:  Xiaoling Zang; José J Pérez; Christina M Jones; María Eugenia Monge; Nael A McCarty; Arlene A Stecenko; Facundo M Fernández
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-31       Impact factor: 3.109

4.  Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice.

Authors:  Munir M Zaman; Camilia R Martin; Charlotte Andersson; Abdul Q Bhutta; Joanne E Cluette-Brown; Michael Laposata; Steven D Freedman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-23       Impact factor: 5.464

Review 5.  Advances in nutritional management of chronic pancreatitis.

Authors:  J C Shea; I K Hopper; P G Blanco; S D Freedman
Journal:  Curr Gastroenterol Rep       Date:  2000-08

6.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

7.  The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells.

Authors:  J X Kang; S F Man; N E Brown; P A Labrecque; M T Clandinin
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

8.  Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism.

Authors:  Charlotte Andersson; M Rabie Al-Turkmani; Juanito E Savaille; Ragheed Alturkmani; Waddah Katrangi; Joanne E Cluette-Brown; Munir M Zaman; Michael Laposata; Steven D Freedman
Journal:  J Lipid Res       Date:  2008-04-25       Impact factor: 5.922

9.  Leukotrienes in the sputum and urine of cystic fibrosis children.

Authors:  A P Sampson; D A Spencer; C P Green; P J Piper; J F Price
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

10.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.